Limd1 Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit

Artikelnummer: BSS-BS-7336R-APC-CY5.5
Artikelname: Limd1 Polyclonal Antibody, APC-Cy5.5 Conjugated, APC/Cy5.5, Rabbit
Artikelnummer: BSS-BS-7336R-APC-CY5.5
Hersteller Artikelnummer: bs-7336R-APC-Cy5.5
Alternativnummer: BSS-BS-7336R-APC-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF
Spezies Reaktivität: Mouse
Konjugation: APC/Cy5.5
Alternative Synonym: AW822033, D9Ertd192e, LIM domain-containing protein 1, LIM domains containing 1, LIMD1, LIMD1_HUMAN, OTTHUMP00000164657, OTTHUMP00000210317, rCG_25194.
The Zyxin family of proteins contains five members: Ajuba, Limd1, LPP, TRIP6 and Zyxin. Limd1 (LIM domain-containing protein 1) is a ubiquitously expressed tumor suppressor containing 3 LIM zinc-binding domains. LIM domains consist of a cysteine-rich consensus sequence containing two distinct zinc-binding subdomains, which mediate protein-protein interactions. Limd1 interacts with the proteins SQSTM1, Rb, p62 and TRAF6. Limd1 was first identified when the deletion of its gene was noted in some cervical cancers. Limd1 blocks in vitro and in vivo tumor growth and is down-regulated in lung cancer. Limd1 may regulate osteoclast development under stressful conditions via its interactions with TRAF6 and p62.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 8994
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human Limd1
Target-Kategorie: Limd1
Application Verdünnung: IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)